Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GDOC vs BHCHX overlap: 51% of top holdings shared

Bottom line

How much do GDOC and BHCHX overlap?

51% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 58.4% of GDOC's assets and 51.0% of BHCHX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

GDOCBHCHX
Weight overlap (top 25)51%
Shared holdings12
Weight in shared holdings58.4%51.0%
Total positions4243
Expense ratio0.75%0.85%
Holdings as ofMay 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Holdings GDOC and BHCHX have in common

Holding% of GDOC% of BHCHXOverlap
Eli Lilly & Company LLY13.28%13.66%13.28%
Johnson & Johnson JNJ8.07%5.56%5.56%
Merck & Company Inc MRK5.94%2.48%2.48%
Guardant Health Inc GH5.34%2.17%2.17%
Astrazeneca Plc AZN4.84%2.49%2.49%
Thermo Fisher Scientific Inc TMO4.52%3.91%3.91%
Argenx Se ARGX4.07%4.23%4.07%
Intuitive Surgical Inc ISRG3.90%1.74%1.74%
Edwards Lifesciences Corp EW2.98%2.64%2.64%
Roivant Sciences Ltd ROIV2.39%3.88%2.39%
Mettler-toledo International Inc MTD1.59%5.60%1.59%
Vertex Pharmaceuticals Inc VRTX1.48%2.61%1.48%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GDOC

  1. Boston Scientific Corp — 3.78%
  2. Hoya Corp — 3.53%
  3. Lonza Group Ag — 2.80%
  4. Dexcom Inc — 2.79%
  5. Agilent Technologies Inc — 2.77%
  6. Cencora Inc — 2.34%
  7. Apogee Therapeutics Inc — 1.97%
  8. Royalty Pharma Plc — 1.77%
  9. Penumbra Inc — 1.61%
  10. Goldman Sachs Trust — 1.43%
  11. Cytokinetics Inc — 1.40%
  12. Ionis Pharmaceuticals Inc — 1.37%
  13. Xenon Pharmaceuticals Inc — 1.35%

Only in BHCHX

  1. Teva Pharmaceutical Industries Ltd — 3.86%
  2. Welltower Inc — 3.38%
  3. UnitedHealth Group Inc — 3.28%
  4. RadNet Inc — 3.24%
  5. Billiontoone Inc — 2.84%
  6. Madrigal Pharmaceuticals Inc — 2.12%
  7. Revolution Medicines Inc — 2.05%
  8. Elanco Animal Health Inc — 2.05%
  9. Kymera Therapeutics Inc — 2.01%
  10. Gilead Sciences Inc — 1.99%
  11. Natera Inc — 1.93%
  12. Protagonist Therapeutics Inc — 1.72%
  13. Elevance Health Inc — 1.69%

Asset mix

Asset typeGDOCBHCHX
Stocks98.5%97.7%
Cash & short-term funds1.4%—

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Country mix

CountryGDOCBHCHX
US76.3%79.7%
GB6.6%2.5%
NL4.1%4.5%
CH3.9%—
BM2.4%3.9%
IL—3.9%
JP3.5%—
CA1.9%1.9%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do GDOC and BHCHX overlap?
About 51% by weight. 12 securities appear in both funds' top 25 holdings; they make up 58.4% of GDOC's assets and 51.0% of BHCHX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do GDOC and BHCHX have in common?
The largest shared holdings are Eli Lilly & Company, Johnson & Johnson, Argenx Se, Thermo Fisher Scientific Inc, Edwards Lifesciences Corp.
Should I own both GDOC and BHCHX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, GDOC or BHCHX?
BHCHX is broader, with 43 positions versus 42 for GDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.